REMINYL 4mg / ml oral solution medication leaflet

N06DA04 galantamine • Nervous system | Anti-dementia drugs | Anticholinesterases

Galantaminum is a medication used for the symptomatic treatment of mild to moderate dementia associated with Alzheimer's disease. It works by inhibiting acetylcholinesterase, thereby increasing acetylcholine levels in the brain and improving cognitive function.

The medication is available in tablet form, extended-release capsules, or oral solution and should be taken as directed by a physician. Galantaminum can help slow the progression of Alzheimer's symptoms.

Common side effects include nausea, vomiting, diarrhea, and dizziness. It is important for patients to be monitored to prevent dehydration or other complications.

Galantaminum is an important therapeutic option for patients with Alzheimer's disease, helping to maintain independence and quality of life.

General data about REMINYL 4mg / ml

Substance: galantamine

Date of last drug list: 01-06-2025

Commercial code: W70775001

Concentration: 4mg / ml

Pharmaceutical form: oral solution

Packing volume: 100ml

Product type: original

Price: 135.36 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: JANSSEN PHARMACEUTICA NV - BELGIA

Holder: JANSSEN-CILAG INTERNATIONAL NV - BELGIA

Number: 13381/2020/01

Shelf life: 3 years-after packaging for sale;after the first opening of the bottle: 3 months

Pharmaceutical forms available for galantamine

Concentrations available for galantamine

12mg, 16mg, 24mg, 4mg, 4mg/ml, 8+16mg, 8mg

Other substances similar to galantamine

Compensation lists for REMINYL 4mg / ml CILAG

G16 (C1) - Dementia (degenerative, vascular, mixed)

Price

Copayment

Patient

135.36 RON

135.36 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

135.36 RON

135.36 RON

0.00 RON